爱尔眼科
(300015)
| 流通市值：639.81亿 | | | 总市值：747.69亿 |
| 流通股本：79.58亿 | | | 总股本：93.00亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 11,945,704,579.95 | 6,396,494,547.19 | 22,352,604,724.87 | 17,483,858,533.8 |
| 营业收入 | 11,945,704,579.95 | 6,396,494,547.19 | 22,352,604,724.87 | 17,483,858,533.8 |
| 二、营业总成本 | 9,126,924,536.72 | 4,825,670,718.98 | 17,711,126,106.58 | 13,272,280,873.59 |
| 营业成本 | 6,436,624,731.86 | 3,343,248,383.02 | 11,821,511,646.26 | 8,868,849,246.64 |
| 税金及附加 | 29,414,457.47 | 15,775,537.23 | 52,992,862.9 | 41,329,424.13 |
| 销售费用 | 1,067,021,603.39 | 562,267,906.79 | 2,145,336,333.3 | 1,633,426,091.19 |
| 管理费用 | 1,310,218,831.67 | 760,098,133.61 | 3,212,807,249.76 | 2,366,594,645.82 |
| 研发费用 | 121,339,568.53 | 61,237,273.87 | 302,482,779.03 | 225,407,008.69 |
| 财务费用 | 162,305,343.8 | 83,043,484.46 | 175,995,235.33 | 136,674,457.12 |
| 其中:利息费用 | 129,489,045.4 | 63,204,523.54 | 269,717,423.59 | 203,731,237.65 |
| 其中:利息收入 | 20,321,896.25 | 7,360,360.57 | 72,167,154.85 | 54,467,738.1 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -21,199,292.1 | -5,000,532.68 | 98,289,797.68 | 20,886,144.35 |
| 加:投资收益 | 24,100,290.18 | 9,927,671.66 | 75,142,848.81 | 22,644,180.68 |
| 资产处置收益 | 7,455,715.47 | 5,425,880.08 | 9,815,580 | 6,280,122.74 |
| 资产减值损失(新) | -1,671,210.49 | - | -157,139,016.29 | -665,015.71 |
| 信用减值损失(新) | -60,549,000.78 | -10,074,847.55 | -144,505,089.44 | -146,067,219.97 |
| 其他收益 | 53,642,716.44 | 26,113,415.43 | 80,012,130.05 | 29,780,559.14 |
| 四、营业利润 | 2,820,559,261.95 | 1,597,215,415.15 | 4,603,094,869.1 | 4,144,436,431.44 |
| 加:营业外收入 | 5,603,435.9 | 2,447,153.45 | 19,742,455.98 | 8,885,467.61 |
| 减:营业外支出 | 230,085,719.86 | 31,783,761.29 | 197,702,323.25 | 113,810,010.07 |
| 五、利润总额 | 2,596,076,977.99 | 1,567,878,807.31 | 4,425,135,001.83 | 4,039,511,888.98 |
| 减:所得税费用 | 1,052,882,115.57 | 253,202,550.55 | 951,915,785.08 | 672,370,908.02 |
| 六、净利润 | 1,543,194,862.42 | 1,314,676,256.76 | 3,473,219,216.75 | 3,367,140,980.96 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 1,543,194,862.42 | 1,314,676,256.76 | 3,473,219,216.75 | 3,367,140,980.96 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 1,357,026,448.97 | 1,180,575,734.31 | 3,240,259,465.09 | 3,114,740,426.82 |
| 少数股东损益 | 186,168,413.45 | 134,100,522.45 | 232,959,751.66 | 252,400,554.14 |
| 扣除非经常损益后的净利润 | 1,514,563,507.48 | 1,175,796,408.9 | 3,140,712,845.49 | 3,119,440,180.4 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.15 | 0.13 | 0.35 | 0.34 |
| (二)稀释每股收益 | 0.15 | 0.13 | 0.35 | 0.34 |
| 八、其他综合收益 | -191,809,868.06 | -117,445,268.76 | 223,202,815.2 | 198,875,334.18 |
| 归属于母公司股东的其他综合收益 | -190,868,378.7 | -117,698,828.83 | 163,399,892.99 | 198,348,634.22 |
| 九、综合收益总额 | 1,351,384,994.36 | 1,197,230,988 | 3,696,422,031.95 | 3,566,016,315.14 |
| 归属于母公司股东的综合收益总额 | 1,166,158,070.27 | 1,062,876,905.48 | 3,403,659,358.08 | 3,313,089,061.04 |
| 归属于少数股东的综合收益总额 | 185,226,924.09 | 134,354,082.52 | 292,762,673.87 | 252,927,254.1 |
| 公告日期 | 2026-08-28 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |